Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Hear From An Expert On How Do You Address Patients' Concerns About Sinus Surgery?

Hear From An Expert On How Do You Address Patients' Concerns About Sinus Surgery?

Hear From An Expert On How Can You Limit The Effects Of Systemic Steroid Use For Patients With Crs With Nasal Polyps?

Hear From An Expert On How Can You Limit The Effects Of Systemic Steroid Use For Patients With Crs With Nasal Polyps?

The superiority of Biologics over OCS for disease modifying potential which explains the superiority over OCS as anti-inflammatory option for our patients with CRSwNP, when we prescribe the Biologicals, we prescribe them long term for chronic disease where we do believe that we do not only aim to reduce inflammation but also to have some disease modifying effects.

Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Expert Opinions: Would You Consider A Biologic For A CRSwnp Patient Who Has Had Sinus Surgery?

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Samenvatting

Thromboprophylaxis in orthopedic surgery

Diagnostic Algorithm for Gaucher Disease in Adult

Diagnostic Algorithm for Gaucher Disease in Adult

Bone Monitoring Guidelines in Gaucher Disease Video

Bone Monitoring Guidelines in Gaucher Disease Video

Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Pediatric

Pligttekst: Apidra<sup>®</sup> SoloStar<sup>®</sup> (insulin glulisin)

Pligttekst: Apidra® SoloStar® (insulin glulisin)

Pligttekst: Cerezyme<sup>®</sup> (Imiglucerase)

Pligttekst: Cerezyme® (Imiglucerase)

Pligttekst: Cablivi<sup>®</sup> (caplacizumab)

Pligttekst: Cablivi® (caplacizumab)

Pligttekst: Sarclisa<sup>®</sup> (isatuximab)

Pligttekst: Sarclisa® (isatuximab)